BioSpace News Archive

Calithera Biosciences, Inc. announced that the compensation committee of the company’s board of directors granted one new employee a non-qualified stock option to purchase an aggregate of 3,500 shares of Calithera’s common stock, at a per share exercise price of $6.13, the closing trading price on April 30, 2020.

Cash conservation and reorganization initiatives coupled with recent financings support cash runway into 2021 under current COVID-19 pandemic assumptions

Trillium Therapeutics Inc., a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, announced that it has established an at-the-market equity program.

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced it has raised gross proceeds of approximately $60 million through its At-the-Market (ATM) facility, $40 million of which came from longtime shareholder, RA Capital Management. The Company sold approximately 3.5 million shares of the Company’s common stock on May 5, 2020, at the then-prevailing market prices. TG Therapeutics intends to use the capital raised through the ATM to fund the ongoing de

Avanos Medical, Inc. reported first quarter 2020 financial results and provided an update on the actions it’s taking in response to the COVID-19 pandemic.

Encouraging signals of durable disease control, including confirmed partial responses in ongoing COM701 Phase 1 dose escalation study

Ionis Pharmaceuticals, Inc. reported its financial results for the first quarter of 2020 and recent business highlights.

Veteran Industry Executive Brings Broad and Varied Experience Across Biotech Sectors

Schrödinger, whose physics-based software platform enables discovery of high-quality, novel molecules for therapeutics and materials, announced that it will host a conference call and webcast on Wednesday, May 13, 2020 at 8:30 a.m. ET to discuss first quarter 2020 financial results and provide a general business update.

BrainsWay Ltd. announced that Hadar Levy has been promoted to Senior Vice President and General Manager of North America, and Judith Huber has been appointed the Company’s Senior Vice President and Chief Financial Officer, effective May 11, 2020.